COVID-19 boosters have arrived — and with them, of course, plenty of debate. While health and administration officials reportedly remain at odds over the proper timeline in which to roll out third doses, unvaccinated hold-outs stand steadfast in their relunctance, writes The New York Times, perhaps even hardening in their skepticism thanks to the "mixed messages" from the booster campaign.
"It seems like such a short time and people are already having to get boosters," said Christopher Poe, an unvaccinated manufacturing worker who grew more skeptical about the shot due to the third-dose discourse. "And the fact that they didn't realize that earlier in the rollout shows me that there could be other questions that could be out there, like the long-term effects."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
5 slow on the draw cartoons about Democrats' response to TrumpCartoons Artists take on taking a stand, staying still as a statue, and more
-
A road trip through ZimbabweThe Week Recommends The country is 'friendly and relaxed', with plenty to see for those who wish to explore
-
The assassination of Malcolm XThe Explainer The civil rights leader gave furious clarity to black anger in the 1960s, but like several of his contemporaries met with a violent end
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
HMPV is spreading in China but there's no need to worryThe Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDAIn the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
